The Effect of Reminiscence Therapy in Elderly

May 7, 2025 updated by: Muş Alparslan University

Psychological Well-Being and Mindfulness in the Elderly: The Effect of Reminiscence Therapy

In this study titled "Psychological Well-Being and Awareness in the Elderly: The Effect of Reminiscence Therapy", patients will be randomly divided into two groups as experimental and control groups. No intervention will be made to the patients in the control group. Reminiscence therapy will be applied to the patients in the experimental group. Participants will be asked to fill out the scale forms after accepting to participate in the study and obtaining their consent. In addition, after the reminiscence therapy is completed, the experimental and control groups will be asked to fill out the post-test forms.

The following questions will be answered in the study;

  • Does reminiscence therapy affect the psychological well-being levels of the elderly?
  • Does reminiscence therapy affect the awareness levels of the elderly?

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

With the aging society in the world and in our country, there is a great need for the development of nursing interventions that will improve and sustain the health and quality of life of the elderly, who are increasingly included in the service area of nurses. It is very important for nurses to perform non-pharmacological practices, which are among their independent functions, not only for the patient but also for their own professional satisfaction. In these services, complementary therapies related to strengthening the personal resources of elderly individuals and ensuring their correct use are important. Therefore, this study aimed to determine the effect of reminiscence therapy applied to elderly individuals on their psychological well-being and awareness levels. In this study titled "Psychological Well-being and Awareness in the Elderly: The Effect of Reminiscence Therapy", patients will be randomly divided into two groups as experimental and control groups. No intervention will be made to the patients in the control group. Reminiscence therapy will be applied to the patients in the experimental group. Participants will be asked to fill out the scale forms after accepting to participate in the study and obtaining their consent. In addition, after the end of the reminiscence therapy, the experimental and control groups will be asked to fill out the final test forms.

The following questions will be answered in the research;

  • Does reminiscence therapy affect the psychological well-being levels of the elderly?
  • Does reminiscence therapy affect the awareness levels of the elderly?

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Turkey
      • Elazığ, Turkey, 23960
        • Recruiting
        • Ağın Community Health Center
        • Contact:
        • Principal Investigator:
          • Güzel Nur Yıldız, Specialst
        • Sub-Investigator:
          • Meltem Çapar Çiftçi, Specialist

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being over 65 years old
  • not having any serious psychiatric disorders
  • not having any diseases such as dementia etc.

Exclusion Criteria:

  • Having a serious psychiatric disorder
  • Not being able to attend sessions during the research process

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Reminiscence Therapy can be applied as 1 or 2 sessions per week and the longest is 1.5 hours, so it will be applied for 5 weeks, 3 days a week (Monday, Wednesday, Friday) with 2 sessions per day. Each session is planned to last an average of 1.5 hours according to the answers from the elderly. The elderly individuals in the experimental group will be divided into 3 groups. Each group will consist of 15 people. The sessions will include, respectively, getting to know each other, childhood, places lived, holidays-festivals, foods-cooking, unforgettable historical periods, favorite music, movies specific to the period, family life-values in life-achievements, evaluation and closing topics.
Other: Reminiscence therapy
Reminiscence Therapy can be applied as 1 or 2 sessions per week and the longest is 1.5 hours, so it will be applied for 5 weeks, 3 days a week (Monday, Wednesday, Friday) with 2 sessions per day. Each session is planned to last an average of 1.5 hours according to the answers from the elderly. The elderly individuals in the experimental group will be divided into 3 groups. Each group will consist of 15 people. The sessions will include, respectively, getting to know each other, childhood, places lived, holidays-festivals, foods-cooking, unforgettable historical periods, favorite music, movies specific to the period, family life-values in life-achievements, evaluation and closing topics.
No Intervention: Control Group
There will be no intervention in the control group during the research process.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological well-being Scale
Time Frame: 1 months
scale score average, It is a single-factor scale consisting of 8 items on a 7-point Likert type. Scores range from 8 to 56. A high score obtained from the scale indicates that the person has many psychological resources and strengths.
1 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Muş Alparslan University

Investigators

  • Principal Investigator: Güzel Nur YILDIZ, Dr, Muş Alparslan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2025

Primary Completion (Estimated)

May 30, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

April 24, 2025

First Submitted That Met QC Criteria

May 7, 2025

First Posted (Actual)

May 9, 2025

Study Record Updates

Last Update Posted (Actual)

May 9, 2025

Last Update Submitted That Met QC Criteria

May 7, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Reminiscence Therapy

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Age-related Cognitive Decline

Clinical Trials on Reminiscence therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe